LAURUS LABS LIMITED

Company Introduction:

LAURUS LABS LIMITED is an Indian pharmaceutical company. It is a leading manufacturer of Active Pharmaceutical Ingredients (APIs), intermediates, and Finished Dosage Forms (FDFs) for various therapeutic areas, including antiretrovirals, oncology, and other chronic diseases. The company is also involved in contract research and manufacturing services.

Type: Factory (Manufacturer)

Laurus Labs Limited manufactures and sells Active Pharmaceutical Ingredients (APIs) and Finished Dosage Forms (FDFs), along with providing contract development and manufacturing services (CDMO) and bio-manufacturing solutions.

The company's API portfolio includes products for Antiretrovirals such as Dolutegravir, Efavirenz, Lamivudine, Tenofovir Disoproxil Fumarate, and Abacavir; Hepatitis C including Sofosbuvir, Ledipasvir, Daclatasvir, and Velpatasvir; Oncology products like Cabazitaxel, Pemetrexed, and Erlotinib; and APIs for Cardiovascular, Anti-diabetic, Respiratory, Gastroenterology, Central Nervous System, and Anti-fungal therapeutic areas.

In Finished Dosage Forms, Laurus Labs focuses on Antiretroviral, Hepatitis C, and Oncology products, offering various tablets and capsules for both domestic and international markets.

Additionally, it offers Custom Synthesis and Contract Development and Manufacturing Organization (CDMO) services for advanced intermediates and APIs to innovator pharmaceutical companies, and engages in Bio-manufacturing for recombinant products and biologics intermediates.